AzTrials
AzTrials

Cervical RadiculopathyDISCNCT06610175

Quantitative Imaging of Cervical Spinal Structures - the DISC Pilot Study -

An observational study of Cervical Radiculopathy and Cervical Myelopathy, run by University Medical Center Groningen at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to explore a multi-parametric quantitative MRI approach to measure cervical intervertebral discs, the spinal cord and its nerve roots in healthy participants and patients with cervical degenerative disc disease (CDDD). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Cervical Radiculopathy, Cervical Myelopathy
What is being tested?
Quantitative MRI and anatomical MRI
Type of treatment
Medical device
How many people
40 participants
Where
1 siteNetherlands
Study dates
26 Jul 2024to Aug 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy participants and patients with symptomatic CDDD with an appointment at the neurosurgical outpatient clinic will be asked to participate in this study.

Who may be able to join

  • Patients with symptomatic CDDD
  • Age ≥18 years
  • One-level or 2-level symptomatic CDDD (radiculopathy, myelopathy or radiculomyelopathy) of cervical levels C4-5, C5-6l, C6-7 or C7-Th1.
  • Sufficient understanding of spoken and written Dutch language
  • Agrees to participate in the obligatory measurements of this study and signed informed consent prior to any study-related procedures.
  • Women who use anticonception or are in their menopause. If this is not the case, a negative pregnancy test is necessary.
Show all 11Show fewer
  • Healthy participants
  • Age-matched healthy participant.
  • Sufficient understanding of spoken and written Dutch language.
  • Agrees to participate in the obligatory measurements of this study and signed informed consent prior to any study-related procedures.
  • Women who use anticonception or are in their menopause. If this is not the case, a negative pregnancy test is necessary

Who cannot join

  • Patients with symptomatic CDDD
  • Multi-segmental (3 or more segments) symptomatic CDDD.
  • Contraindication for an MRI scan (e.g. implanted non-MRI-compatible devices or foreign bodies, claustrophobic or pregnancy).
  • A positive pregnancy test.
  • Allergy for contrast medium.
  • Previous history of cervical spine surgery.
Show all 12Show fewer
  • Healthy participants
  • Contraindication for an MRI scan (e.g. implanted non-MRI-compatible devices or foreign bodies, claustrophobic or pregnancy).
  • A positive pregnancy test.
  • Allergy for contrast medium.
  • Previous history of cervical spine surgery.
  • Complaints of symptomatic CDDD (radiating arm/neck pain, tingling fingers, loss of strength or changed sensibility in one of the upper extremities).

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • University Medical Center Groningen

    Groningen

Other trials in Netherlands

About this study

Official title: Quantitative Imaging of Cervical Spinal Structures in Healthy Participants and Patients With Cervical Degenerative Disc Disease - the DISC Pilot Study -

The aim of this study is to explore a multi-parametric quantitative MRI approach to measure cervical intervertebral discs, the spinal cord and its nerve roots in healthy participants and patients with cervical degenerative disc disease (CDDD).

CDDD is the consequence of degeneration of intervertebral discs and joints leading to symptoms of cervical radiculopathy, myelopathy, or a combination of both. The incidence of symptomatic CDDD is rising with the aging population, and, consequently, a significant increase in surgeries for symptomatic CDDD is predicted in the upcoming years. However, the decision for- and optimal timing of surgery remain challenging.

Read more

Currently, the decision for surgery in patients with symptomatic CDDD is related to symptoms, as well as position and size of disc herniation on conventional Magnetic Resonance Imaging (MRI). However, conventional MRI only enables qualitative morphological evaluation, leaving space for subjective individual interpretation. Also, disc herniations on conventional MRI are frequently found in asymptomatic individuals, while, in symptomatic individuals type and extent of disc herniation does not correlate to severity of symptoms. Altogether, the current standard using conventional MRI cannot optimally predict response to surgery for patients with symptomatic CDDD.

The primary aim of this project is to investigate whether a combination of different quantitative imaging sequences can provide more detailed information on disc herniation related compression and potentially aid in determining more objective cut-offs to stage disc herniation in patients with symptomatic CDDD, as well as to analyze whether differences exist in quantitative imaging parameters of discs in healthy participants versus patients with symptomatic CDDD. These novel techniques are promising, as they are noninvasive and could potentially aid in determining objective cut-offs to stage disc herniation. Since no single measurement has been proven to be the golden standard in previous studies, it is likely that a combination of measurements is needed for clinical application

Read the detailed description

RATIONALE:

Cervical degenerative disc disease (CDDD) is the consequence of degeneration of intervertebral discs and joints and can result in compression of the cervical nerve root leading to clinical symptoms of radiculopathy, compression of the spinal cord with symptoms of myelopathy, or a combination of both.The incidence of CDDD is rising with the aging population, and, consequently, a significant increase insurgeries for symptomatic CDDD is predicted in the upcoming years. As such, the decision for- and optimal timing of surgery remain challenging.

Currently, the decision for surgery in patients with symptomatic CDDD is related to symptoms, as well as position and size of disc herniation on conventional Magnetic Resonance Imaging (MRI). However, conventional MRI only enables qualitative morphological evaluation, leaving space for subjective individual interpretation. Also, disc herniations on conventional MRI are frequently found in asymptomatic individuals, while, in symptomatic individuals type and extent of disc herniation does not correlate to severity of symptoms. Altogether, the current standard using conventional MRI cannot optimally predict response to surgery for patients with symptomatic CDDD.

Quantitative imaging is rapidly being recognized as a supplement to conventional MRI and refers to the direct measurement of physical properties of tissue. These novel techniques are promising, as they are noninvasive and could potentially aid in determining objective cut-offs to stage disc herniation. Diffusion tensor imaging (DTI) is one of the most studied quantitative techniques and allows for evaluation of microstructural changes. The DTI fractional anisotropy (FA) metric was demonstrated as valid biomarker for recovery after surgery in cervical myelopathy as well as surgical selection in lumbar radiculopathy. Moreover, recent introduction of zoomed-DTI (z-DTI) could lead to greater imaging accuracy while proven feasible in the cervical spine.

Furthermore, the cervical spinal cord and its nerve roots are highly vascularized and their perfusion could be compromised by disc-herniation related compression. Using the endogenous perfusion technique arterial spin labeling (ASL), as well as contrast-based perfusion techniques such as susceptibility contrast (DSC) and dynamic contrast enhanced (DCE), degree of ischemia, hypoxia as well as signal enhancement can be estimated. ASL has been studied twice for spinal cord perfusion mapping and DSC was demonstrated feasible in the spine of healthy participants as well as patients with cervical myelopathy. Additionally, increased signal enhancement was observed for DCE in degenerative discs of the lumbar spine. To our best knowledge, no studies have been conducted to assess perfusion of the cervical nerve roots, which are compromised in cervical radiculopathy due to CDDD.

Besides microstructure and perfusion, viscoelastic properties of cervical spinal structures may change in relation to disc herniation-related compression. Therefore, it would be interesting to study mechanical properties such as stiffness and viscosity, which can be measured with Tomo-MRElastography (TMRE). To our best knowledge, no previous study has assessed cervical intervertebral discs and spinal structures using TMRE, making this a promising first study.

Finally, imaging is a relatively time-consuming matter, and including additional sequences will only increase its lengthiness. Therefore, several methods are being developed to perform imaging in a more efficient manner. One novel method is Synthetic MRI (SyMRI). Advantages of SyMRI are a reduced acquisition time, possibility of performing automatic tissue segmentation and volume estimation and acquisition of quantitative parameters. SyMRI has been studied once in the spine, and significant differences in quantitative intervertebral disc values were found in relation to hydration-status of the disc.

Since no single measurement has been proven to be the golden standard in previous studies, it is likely that a combination of measurements is needed for clinical application. Therefore, the aim of this pilot study is to explore a multi-parametric quantitative MRI approach including z-DTI, ASL, DSC, DCE, TMRE, and SyMRI to measure cervical intervertebral discs, the spinal cord and its nerve roots.

OBJECTIVE:

This study will consist of three parts. The primary objective of part 1 is to evaluate feasibility of the quantitative MRI sequences (e.g. z-DTI, ASL, DSC, DCE, TMRE, and SyMRI) for assessment of cervical spinal structures (e.g. intervertebral discs, spinal cord, and nerve roots) in healthy participants and patients with symptomatic CDDD. The primary objective of part 2 is to determine a correlation between the quantitative MRI sequences of cervical spinal structures to clinical outcome in patients with symptomatic CDDD. Finally, the primary aim of part 3 is to establish a correlation between quantitative MRI sequences of cervical spinal structures and surgical treatment within 6 months of follow-up.

STUDY DESIGN:

A prospective pilot study.

STUDY POPULATION:

The study population consists of healthy participants and patients with symptomatic CDDD with radiculopathy, myelopathy, or radiculomyelopathy. Age-matched healthy participants will be included. Participants have no previous history of cervical disc herniation or cervical surgery, a sufficient understanding of the Dutch language and no contraindications for an MRI scan.

INTERVENTION:

All participants will be subjected to several MRI sequences, using a state of the art 3T Siemens MRI Scanner available in the UMCG. First, all participants (healthy participants and patients with symptomatic CDDD) undergo baseline neurologic examination. Additionally, participants fill out the following questionnaires: Neck Disability Index (NDI), Visual Analogue Scale (VAS) for arm and neck pain, modified Japanese Orthopedic Association (mJOA), Nurick grade, EuroQol 5-Dimension 5-Level (EQ-5D-5L), Work Ability Single Item (WAI-SI), and Central Sensitisation Inventory (CSI). All participants undergo MRI scanning: localizer \& T2-weighted anatomical (conventional MRI), z-DTI, ASL, DSC, DCE, TMRE, and SyMR. The total scanning time will be approximately 40 minutes. For assessment of reproducibility, 10 healthy participants and 10 patients will be scanned 2 times on different days/times. The patients with symptomatic CDDD will have another study visit after 6 months of follow-up to assess their treatment status (having had surgery yes/no; in case of yes also the surgery characteristics), to fill out the abovementioned questionnaires and have an MRI with additional sequences.

MAIN STUDY PARAMETERS/ENDPOINTS:

Primary endpoints are the technical feasibility and repeatability for the quantitative MRI sequences (i.e. z_DTI, ASL, DSC, DCE, TMRE, and SyMRI) of cervical spinal structures (i.e. intervertebral discs, spinal cord, and nerve roots) in healthy participants and patients with symptomatic CDDD. Also, a correlation of quantitative MRI sequences of cervical spinal structures to clinical impairment in patients with symptomatic CDDD will be determined. Clinical impairment will be measured with the Neck Disability Index (NDI) for cervical radiculopathy, modified Japanese Orthopaedic Association Score (mJOA) for cervical myelopathy, and NDI as well as mJOA for radiculomyelopathy.

NATURE AND EXTENT OF THE BURDER AND RISKS ASSOCIATED WITH PARTICIPATION, BENEFIT AND GROUP RELATEDNESS:

All participants (healthy and patients) will need a conventional MRI scan with quantitative MRI sequences, which will take approximately 40 minutes. Most MRI sequences used in this study are noninvasive and do not involve any ionizing radiation. However, DSC and DCE require administration of a bolus contrast. The contrast agent that will be used is Dotarem. Without any contra-indications for an MRI scan or contrast agent, health is not at risk. There is an overall negligible risk for participants, as based on the Risk Classification Checklist of the NFU. Therefore, the investigators can conclude that this study is a low-risk study.

Being tested
Quantitative MRI and anatomical MRI
Medical subject headings
Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quantitative MRI and anatomical MRIDevice

    Also called zoomed-DTI, Arterial Spin Labelling (ASL), Diffusion Susceptibility Contrast (DSC), Dynamic Contrast Enhanced (DCE), Synthethic MRI (SyMRI), Tomo-MR-Elastography (TMRE)

    The total scanning time will be approximately 40 minutes. Additionally, 10 healthy participants and 10 patients with symptomatic CDDD will undergo a second MRI with additional sequences for assessment of reproducibility on another day/time. Also: included participants will undergo neurologic examination and fill out questionnaires for NDI, VAS-arm, VAS-neck, WA-SI, EQ-5D-5L, CSI, mJOA and Nurick.

Study groups in NCT06610175
Study groupRoleWhat they receive
Healthy participantsNot described
Receives: Device: Quantitative MRI and anatomical MRI
Patients with CDDDNot described
Receives: Device: Quantitative MRI and anatomical MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantitative MRI sequences

    Technical feasibility and repeatibility of quantitative MRI sequences (i.e. z-DTI, ASL, DSC, DCE, SyMRI, and TMRE) of cervical spinal structures (i.e. intervertebral disc, spinal cord, and nerve roots) in healthy participants and patients with symptomatic CDDD.

    Measured: MRI conducted at study visit (baseline)

  2. Clinical correlation of quantitative MRI sequences and clinical impairment in patients with symptomatic CDDD

    To determine a correlation of quantitative MRI sequences of cervical spinal structures to clinical impairment in patients with symptomatic CDDD. Clinical impairment will be measured with the Neck Disability Index (NDI) for cervical radiculopathy, modified Japanese Orthopaedic Association Score (mJOA) for cervical myelopathy, and NDI as well as mJOA for cervical radiculomyelopathy.

    Measured: MRI and clinical examinations conducted at study visit (baseline)

  3. To determine a correlation between baseline quantitative MRI sequences of cervical spinal structures and surgical treatment after 6 months of follow-up in patients with symptomatic CDDD as well as clinical outcomes assessed at 6 months of follow-up.

    Measured: 6 months

  4. Comparison CSI

    To make a comparison of the CSI-score in healthy participants with bulging discs on MRI compared to patients with symptomatic CDDD.

    Measured: During first study visit

Secondary outcomes (4)
  1. Correlation between quantitative MRI sequences of the cervical spinal cord with extent of compression on anatomical MRI (cross-sectional area spinal cord) in healthy participants and patients with symptomatic CDDD.

    Extent of compression on anatomical MRI is measured as a ratio between the diameter of the spinal canal and spinal cord as well as with different shape analysis and segmentations.

    Measured: Comparison made at baseline and for patients with symptomatic CDDD also at 6 months follow-up

  2. Between-group analyses comparing quantitative MRI sequences of cervical spinal structures of healthy participants to subgroups of patients

    Patients with symptomatic CDDD as a whole group, only patients with cervical radiculopathy, only patients with cervical myelopathy

    Measured: MRI conducted at baseline and at 6 months follow-up in the patients with symptomatic CDDD

  3. Comparison of quantitative MRI sequences of cervical spinal structures in healthy participants and patients with symptomatic CDDD to available values in literature.

    Measured: Assessed during study visit

  4. To determine a correlation of quantitative MRI sequences of cervical spinal structures to clinical outcomes

    Clinical outcomes measured with Visual Analogue Scale (VAS)-arm, VAS-neck, Nurick grade, EuroQol 5- Dimension 5-Level (EQ-5D-5L), and Work Ability Single item (WA-S

    Measured: MRI conducted at baseline and at 6 months follow-up in the patients with symptomatic CDDD

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2024
  2. Study start26 Jul 2024
  3. Primary completionJan 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06610175
Sponsor's protocol ID
16948
Acronym
DISC
Status last verified
May 2024
First submitted
22 May 2024
Last updated
6 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cervical Radiculopathy and Cervical Myelopathy, run by University Medical Center Groningen at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantitative MRI sequences (time frame: MRI conducted at study visit (baseline)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in